Pfizer has announced that it is pulling out of early-stage research into Alzheimer’s and Parkinson’s disease after investing heavily in the area in recent years.
Chemist Warehouse tests drone deliveries
Priceline teams up with Guild
Rethink on iron supplement dosage
Your Australian Doctor Group network login gives you access to Australian Doctor, How To Treat, 6minutes, and Pharmacy News